D C Mann, L A Pearce, L D Waterbury. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAmantadine/adverse effectsAmantadine/therapeutic useAmines/cerebrospinal fluidAmines/urineBrain/physiopathologyClinical Trials as TopicDihydroxyphenylalanine/therapeutic useDisability EvaluationElectroencephalographyFemaleHumansMaleMiddle AgedMovement Disorders/drug therapyMuscular Diseases/drug therapyParkinson Disease/drug therapyParkinson Disease/metabolismParkinson Disease/physiopathologyPlacebosTremor/drug therapy
Substances: See more » AminesPlacebosDihydroxyphenylalanineAmantadine
Year: 1971 PMID: 4936828 DOI: 10.1212/wnl.21.9.958
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910